Atherosclerosis and Lipoproteins |
Cys) on Cholesterol Levels and Atherosclerosis in ApoE-Deficient Mice
From the Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research (M.V.E., N.H., T.J.C.V.B.), the Department of Human Genetics (K.W.V.D., M.H.H.), Sylvius Laboratories, Leiden University, and TNO Prevention and Health (L.M.H.), Leiden, The Netherlands; and SmithKline Beecham Pharmaceuticals (P.H.E.G.), NFSP(N), Coldharbour Road, Harlow, Essex CM19 5AD, UK.
Correspondence to M. Van Eck, MSc, Division of Biopharmaceutics, Sylvius Laboratories, Leiden University, PO Box 9503, 2300 RA Leiden, The Netherlands. E-mail M.Eck{at}LACDR.LeidenUniv.nl
AbstractThe effect of
monocyte/macrophage-derived wild-type mouse apolipoprotein
E (apoE), human apoE3-Leiden, and human apoE2 on serum
cholesterol levels and the development of
atherosclerosis in apoE-deficient
(apoe/) mice was investigated by using bone marrow
transplantation (BMT). At 4 weeks after BMT, murine
apoe+/+ bone marrow reduced serum
cholesterol levels by 87% in apoe/
mice, whereas macrophage-derived human apoE3-Leiden and
human apoE2 induced a maximal, transient reduction of 35% and 48%,
respectively. At 4 months after BMT, atherosclerosis
was 23-fold (P<0.001) reduced in
apoe+/+
apoe/ mice, whereas no
significant reduction in
apoE3-Leiden.apoe/
apoe/ and
apoE2.apoe/
apoe/ mice could be
demonstrated. A highly significant decrease in serum
cholesterol levels (78% reduction) and
atherosclerosis (21-fold, P<0.001) was
found in apoE3-Leiden.apoe/ animals expressing high
levels of apoE in multiple tissues, whereas apoE2 was ineffective even
at high concentrations. Furthermore, in contrast to apoE-deficient
macrophages, cholesterol efflux from apoE2 or
apoE3-Leiden macrophages was not impaired. In conclusion,
apoE3-Leiden as well as apoE2 are less effective in reducing
cholesterol levels and atherosclerosis in
apoe/ animals, compared with apoe+/+,
with apoE2<apoE3-Leiden<apoe+/+, irrespective of the
observed adequate efflux of cholesterol from
macrophages expressing apoE2 and apoE3-Leiden, indicating that
normalization of cholesterol efflux by macrophages
is not accompanied by measurable effects on lesion growth.
Key Words: apolipoprotein E atherosclerosis hyperlipidemia macrophages bone marrow transplantation
This article has been cited by other articles:
![]() |
A. H. Hasty, M. R. Plummer, K. H. Weisgraber, M. F. Linton, S. Fazio, and L. L. Swift The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I J. Lipid Res., July 1, 2005; 46(7): 1433 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fosslien Mitochondrial Medicine - Molecular Pathology of Defective Oxidative Phosphorylation Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 25 - 67. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |